Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

about

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

Item

http://www.wikidata.org/entity/Q57116389

description

scientific article published on 29 June 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в липні 2018

@uk

name

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

@en

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

@nl

type

Item

label

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

@en

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

@nl

prefLabel

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

@en

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

@nl

P1476

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

@en

P2093

William R Jarnagin

http://www.w3.org/2001/XMLSchema#string

P2860

Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system

Staging laparoscopy in patients with extrahepatic biliary carcinoma. Analysis of 100 patients

Cancer statistics, 2016

The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review.

Selection for hepatic resection of colorectal liver metastases: expert consensus statement

ADENOCARCINOMA OF THE HEPATIC DUCT AT ITS BIFURCATION WITHIN THE PORTA HEPATIS. AN UNUSUAL TUMOR WITH DISTINCTIVE CLINICAL AND PATHOLOGICAL FEATURES.

Concurrent chemoradiotherapy in resected extrahepatic cholangiocarcinoma.

Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.

Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients.

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer.

P304

304-312

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AGS3.12181

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael E Lidsky

P577

2018-06-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30003193

http://www.w3.org/2001/XMLSchema#string

P932

6036362

http://www.w3.org/2001/XMLSchema#string